Dr. Thiele reported research funding from several pharmaceutical and device firms. Dr. Hoppe did not provide disclosures. The trial was funded by the German Research Foundation, the German Heart Research Foundation, and other organizations, as well as by Maquet Cardiopulmonary and Teleflex Medical.
AT THE ANNUAL CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY